Page last updated: 2024-10-22

albuterol and Diathesis

albuterol has been researched along with Diathesis in 3 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research Excerpts

ExcerptRelevanceReference
"Fifty children primarily with moderate-to-severe asthma were followed with measurements of urinary LTE(4), monitoring of FEV(1), and albuterol use."7.73Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. ( Gelfand, EW; Rabinovitch, N; Zhang, L, 2006)
"Fifty children primarily with moderate-to-severe asthma were followed with measurements of urinary LTE(4), monitoring of FEV(1), and albuterol use."3.73Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. ( Gelfand, EW; Rabinovitch, N; Zhang, L, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denlinger, LC1
Phillips, BR1
Ramratnam, S1
Ross, K1
Bhakta, NR1
Cardet, JC1
Castro, M1
Peters, SP1
Phipatanakul, W1
Aujla, S1
Bacharier, LB1
Bleecker, ER1
Comhair, SA1
Coverstone, A1
DeBoer, M1
Erzurum, SC1
Fain, SB1
Fajt, M1
Fitzpatrick, AM1
Gaffin, J1
Gaston, B1
Hastie, AT1
Hawkins, GA1
Holguin, F1
Irani, AM1
Israel, E1
Levy, BD1
Ly, N1
Meyers, DA1
Moore, WC1
Myers, R1
Opina, MT1
Peters, MC1
Schiebler, ML1
Sorkness, RL1
Teague, WG1
Wenzel, SE1
Woodruff, PG1
Mauger, DT1
Fahy, JV1
Jarjour, NN1
Marotta, A1
Klinnert, MD1
Price, MR1
Larsen, GL1
Liu, AH1
Rabinovitch, N1
Zhang, L1
Gelfand, EW1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Severe Asthma Research Program (SARP) - University of Wisconsin[NCT01760915]107 participants (Actual)Observational2012-11-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for albuterol and Diathesis

ArticleYear
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.
    American journal of respiratory and critical care medicine, 2017, 02-01, Volume: 195, Issue:3

    Topics: Adolescent; Adult; Albuterol; Asthma; Biomarkers; Body Mass Index; Breath Tests; Bronchodilator Agen

2017

Other Studies

2 other studies available for albuterol and Diathesis

ArticleYear
Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma.
    The Journal of allergy and clinical immunology, 2003, Volume: 112, Issue:2

    Topics: Airway Resistance; Albuterol; Asthma; Bronchial Hyperreactivity; Bronchodilator Agents; Child, Presc

2003
Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction.
    The Journal of allergy and clinical immunology, 2006, Volume: 118, Issue:3

    Topics: Acetates; Adolescent; Airway Obstruction; Albuterol; Asthma; Child; Chronic Disease; Cyclopropanes;

2006